---
title: "Curative Biotechnology, Inc. (CUBT.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/CUBT.US.md"
symbol: "CUBT.US"
name: "Curative Biotechnology, Inc."
industry: "生物技術"
---

# Curative Biotechnology, Inc. (CUBT.US)

| Item | Detail |
|------|--------|
| Industry | 生物技術 |
| Location | 美股市場 |
| Website | [curativebiotech.com](https://curativebiotech.com) |

## Company Profile

Curative Biotechnology, Inc.是一家生物制藥公司，專注于識別、許可和開發針對罕見疾病的治療藥物候選者。它開發了二甲雙胍重配方用于治療中間型幹性黃斑變性和地理性萎縮；IMT504，一種新型免疫療法，用于治療晚期狂犬病；以及 CUBT906，一種完全人源化的 CD56 單克隆抗體，攜帶細胞毒性藥物結合物，直接作用于腫瘤部位，通過抑制腫瘤生長和遷移來殺死腫瘤。該公司與 Mid-Atlantic BioTherapeutics, Inc.簽訂了許可和共同開發協議，以開發 IMT504 用于治療晚期狂犬病和 COVID-19 疫苗

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -2.73 | 294/605 | - | - | - |
| PB | -1.32 | 493/605 | - | - | - |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/CUBT.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/CUBT.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/CUBT.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.